Pace(R) Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025
MINNEAPOLIS, MN / ACCESSWIRE / January 10, 2025 / Pace® Life Sciences, LLC, a U.S.-based contract research, development, and ...
BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)
ORLADEYO net revenue expected to be between $515-$535 million in 2025——Total revenue (including RAPIVAB®) expected to be between $540-$560 ...
The Business Journals20h
Raleigh/Durham News
© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...